Liu M, Mu T, Gu J, Xu M, Chen S
Cancer Rep (Hoboken). 2025; 8(3):e70167.
PMID: 40033897
PMC: 11876780.
DOI: 10.1002/cnr2.70167.
Duan C, Sheng J, Ma X
Therap Adv Gastroenterol. 2025; 18:17562848251314829.
PMID: 39898356
PMC: 11783499.
DOI: 10.1177/17562848251314829.
Emelyanova M, Ikonnikova A
World J Gastroenterol. 2024; 30(46):4950-4957.
PMID: 39679308
PMC: 11612711.
DOI: 10.3748/wjg.v30.i46.4950.
Liu Q, Ye Y, Jia X
World J Gastroenterol. 2024; 30(44):4741-4744.
PMID: 39610773
PMC: 11580609.
DOI: 10.3748/wjg.v30.i44.4741.
Wang B, Zhang Y, Liu J, Deng B, Li Q, Liu H
BMC Med. 2024; 22(1):560.
PMID: 39604913
PMC: 11600563.
DOI: 10.1186/s12916-024-03777-2.
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.
Mannucci A, Goel A
Mol Cancer. 2024; 23(1):259.
PMID: 39558327
PMC: 11575410.
DOI: 10.1186/s12943-024-02174-w.
The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer.
Chen Q, Xu Y, Kang S, Lin W, Luo L, Yang L
MedComm (2020). 2024; 5(12):e70011.
PMID: 39554798
PMC: 11564342.
DOI: 10.1002/mco2.70011.
Circulating tumor cells: from new biological insights to clinical practice.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
Integration of multiomics features for blood-based early detection of colorectal cancer.
Gao Y, Cao D, Li M, Zhao F, Mei S, Song Q
Mol Cancer. 2024; 23(1):173.
PMID: 39175001
PMC: 11340186.
DOI: 10.1186/s12943-024-01959-3.
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology.
Tan W, Nagabhyrava S, Ang-Olson O, Das P, Ladel L, Sailo B
Curr Issues Mol Biol. 2024; 46(7):6533-6565.
PMID: 39057032
PMC: 11276574.
DOI: 10.3390/cimb46070390.
Genome wide identification of novel DNA methylation driven prognostic markers in colorectal cancer.
Ma Y, Li Y, Wen Z, Lai Y, Kamila K, Gao J
Sci Rep. 2024; 14(1):15654.
PMID: 38977698
PMC: 11231291.
DOI: 10.1038/s41598-024-60351-9.
Early Diagnosis of Colorectal Cancer Based on Bisulfite-free Site-specific Methylation Identification PCR Strategy: High-Sensitivity, Accuracy, and Primary Medical Accessibility.
Zhen L, Tang X, Xu Z, Huang Y, Qian X, Lin H
Adv Sci (Weinh). 2024; 11(33):e2401137.
PMID: 38868913
PMC: 11434020.
DOI: 10.1002/advs.202401137.
Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.
Mondal D, Shinde S, Sinha V, Dixit V, Paul S, Gupta R
Front Mol Biosci. 2024; 11:1385238.
PMID: 38770216
PMC: 11103528.
DOI: 10.3389/fmolb.2024.1385238.
Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer.
Wang Y, Wang J, He J, Ji B, Pang Z, Wang J
Front Immunol. 2023; 14:1289198.
PMID: 38022515
PMC: 10657824.
DOI: 10.3389/fimmu.2023.1289198.
An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects.
Xue Y, Huang C, Pei B, Wang Z, Dai Y
Front Genet. 2023; 14:1234645.
PMID: 37560387
PMC: 10407555.
DOI: 10.3389/fgene.2023.1234645.
Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer.
Xin L, Yue Y, Zihan R, Youbin C, Tianyu L, Rui W
Front Physiol. 2023; 14:1200124.
PMID: 37351260
PMC: 10282751.
DOI: 10.3389/fphys.2023.1200124.
A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes.
Yang G, Yu X, Weisenberger D, Lu T, Liang G
Cancers (Basel). 2023; 15(11).
PMID: 37296894
PMC: 10251979.
DOI: 10.3390/cancers15112934.
Screening for pancreatic cancer has the potential to save lives, but is it practical?.
Mazer B, Lee J, Roberts N, Chu L, Lennon A, Klein A
Expert Rev Gastroenterol Hepatol. 2023; 17(6):555-574.
PMID: 37212770
PMC: 10424088.
DOI: 10.1080/17474124.2023.2217354.
Epigenetic liquid biopsies for minimal residual disease, what's around the corner?.
Johnston A, Ross J, Ma C, Fung K, Locke W
Front Oncol. 2023; 13:1103797.
PMID: 37081990
PMC: 10110851.
DOI: 10.3389/fonc.2023.1103797.
IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers.
Haslund-Gourley B, Wigdahl B, Comunale M
Diagnostics (Basel). 2023; 13(6).
PMID: 36980324
PMC: 10047871.
DOI: 10.3390/diagnostics13061016.
